When did I ovulate and which seeds are best to consume for fertility, given my luteinizing hormone (LH) levels, estrogen (E1g) levels, progesterone (Pdg) levels, and symptoms such as cramps, nipple sensitivity, and ewcm (egg white cervical mucus)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 17, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Timing of Ovulation Based on Your Hormone Data

Based on your LH surge pattern and supporting symptoms, you most likely ovulated in the late evening of CD13 or early morning of CD14, approximately 24-36 hours after your LH began rising on CD13.

Analysis of Your Ovulation Timing

LH Surge Pattern

  • Your LH began rising on CD13 (12.3 FMU → 26.7 at 6:15pm), indicating the start of your LH surge 1, 2
  • CD14 showed peak LH values (45 at 9:30am), which is the critical marker for ovulation timing 1, 3
  • Ovulation occurs 28-36 hours after the LH rise begins or 8-20 hours after the LH peak 1
  • Your LH remained elevated through CD14 evening (22 at 7:30pm) before declining on CD15, consistent with typical surge duration of 24-30 hours 1

Supporting Hormonal Evidence

  • E1G (estrogen) pattern: Progressive rise from CD13 (176.2) → CD14 (215.1) → CD15 (258.6) is consistent with pre-ovulatory follicle development 2, 4
  • PDG (progesterone) pattern: Remained low on CD13-14 (1.5-1.6), then dropped to 1.1 on CD15, which is expected immediately post-ovulation before corpus luteum fully activates 2
  • The reciprocal relationship between your rising estrogen and stable low progesterone during CD13-14 confirms pre-ovulatory status 1

Clinical Symptoms Correlation

  • EWCM on CD14 aligns perfectly with peak fertility and imminent ovulation 1
  • Cramps throughout CD14 until 6pm likely represent follicular distension and ovulation pain 1
  • Pulling/achy cramps at 2am CD15 (one hour duration) strongly suggest the actual moment of follicular rupture 1
  • Post-ovulatory symptoms on CD15 (nipple sensitivity, flushed cheeks, body warmth) with no cramps indicate the luteal phase has begun 2

Seed Cycling Recommendation for Luteal Phase

You should now consume pumpkin seeds and flax seeds during your luteal phase (CD15 onwards).

Luteal Phase Seeds (Days After Ovulation Until Menstruation)

  • Pumpkin seeds: 1-2 tablespoons daily 5
  • Flax seeds: 1-2 tablespoons daily (ground for better absorption) 5

Rationale

  • These seeds are traditionally used to support progesterone production during the luteal phase 5
  • Pumpkin seeds contain zinc and magnesium, which support corpus luteum function 5
  • Flax seeds contain lignans that may help balance estrogen-to-progesterone ratios 5

Important Caveats

  • The evidence for seed cycling improving fertility outcomes is limited and not supported by high-quality clinical trials 5
  • Supplements and nutritional interventions for fertility have "questionable clinical utility" according to reproductive medicine guidelines 5
  • Adequate overall nutrition and energy availability are far more important than specific seed consumption 5
  • Ensure you maintain adequate caloric intake (>30 kcal/kg fat-free mass/day) to avoid disrupting your menstrual cycle 5

When to Resume Follicular Phase Seeds

  • Switch to sesame and sunflower seeds on the first day of your next menstrual period through ovulation 5

Monitoring Recommendation

  • Your progesterone (PDG) should rise significantly by 7 days post-ovulation (approximately CD21-22 in your cycle) to confirm ovulation occurred 6, 7
  • A PDG level ≥5 ng/ml (or urinary PDG equivalent) would confirm successful ovulation and corpus luteum function 6

References

Research

Ovulation detection in the human.

Clinical reproduction and fertility, 1982

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Day 21 Progesterone Level as an Indicator of Ovulation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Timing of Hormone Labs for Secondary Infertility Evaluation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

When did ovulation occur and how long is the egg viable for fertilization in a woman with a menstrual cycle, experiencing mittelschmerz, and having LH (Luteinizing Hormone) levels of 12.3, 26.7, 45, 22, and 12.1, and EWCM (Egg White Cervical Mucus) on cycle day 14?
Does the luteinizing hormone (LH) surge decrease after ovulation occurs?
When did I ovulate and which seeds should I consume to support implantation and early pregnancy, given my luteinizing hormone (LH) levels and fertile cervical mucus (FCM) on cycle days 13 and 14?
When did I ovulate, how long is the egg viable for, and when is the optimal time for intercourse to conceive, given my hormone levels, including luteinizing hormone (LH) and estrogen (E1g) levels, and physical symptoms such as egg white cervical mucus (EWCM), cramps, and nipple sensitivity, during my menstrual cycle?
How do you measure ovulation with Follicle-Stimulating Hormone (FSH), Luteinizing Hormone (LH), and progesterone?
What is the recommended weekly intramuscular (IM) dose of methylcobalamin (Vitamin B12) for a patient with a confirmed deficiency or increased demand, such as pernicious anemia?
What is the most suitable research design for investigating food poisoning in travelers who have recently returned from a trip?
What is the recommended initial intravenous (IV) dose of Metoprolol (beta blocker) for an adult patient presenting with tachycardia?
What is the recommended antibiotic treatment for a patient with a Burkholderia cepacia infection?
What is the mortality rate for elderly hemodialysis patients with diabetes and cardiovascular disease in a specific location?
What are the risks of using GLP-1 (Glucagon-like peptide-1) agonists, such as exenatide (Byetta), liraglutide (Victoza), and dulaglutide (Trulicity), in patients with diabetes who are at risk of developing gastroparesis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.